Identifying gaps across the cascade of care for the prevention of HBV mother-to-child transmission in Burkina Faso: Findings from the real world.
Burkina Faso
/ epidemiology
Child
Female
Hepatitis B
/ diagnosis
Hepatitis B Surface Antigens
Hepatitis B Vaccines
Hepatitis B e Antigens
Hepatitis B virus
/ genetics
Humans
Infant
Infectious Disease Transmission, Vertical
/ prevention & control
Pilot Projects
Pregnancy
Pregnancy Complications, Infectious
/ diagnosis
Prospective Studies
Prenatal consultation
mother-to-child transmission
tenofovir
vaccination
viral hepatitis B
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
11
11
2019
revised:
01
01
2020
accepted:
01
07
2020
pubmed:
8
7
2020
medline:
22
6
2021
entrez:
8
7
2020
Statut:
ppublish
Résumé
Prevention of mother-to-child transmission (PMTCT) is a challenge for controlling the hepatitis B epidemic. In Sub-Saharan countries, pilot interventions including the screening of pregnant women for HBsAg, implementation of anti-HBV therapy and infant immunization within 24 hours of life are initiated and need to be evaluated. This pilot study aimed to describe the cascade of care for hepatitis B PMTCT in a real life situation, and to identify sociodemographic factors associated with adequate management of pregnant women and infants. The study was conducted from October 1st, 2014 to February 28th, 2016 in the antenatal clinics (ANCV) of Baskuy district which comprises nine first-level public health centres. Univariate and multivariate logistic regression analysis were used to identify sociodemographic factors associated with the likelihood of retention in the cohort, HBV DNA testing, birth dose delivery and HBsAg testing of the children at 6 months of age; P ˂ .05 was selected as cut off for significance. In this prospective cohort study, of 5200 pregnant women consulting for the antenatal visit, 2261 (43.5%) were proposed pre-test counselling and HBsAg screening and 2220 (98.2%) have agreed to screening. Among 1580 (71.2%) women that came back for the post-counselling interview, 75 were positive for HBsAg (4.8%), 73 (97.3% of the women provided HBsAg result) consented to medical consultation with hepatogastroenterologists and 53 (72.6%); performed the HBV DNA testing. Forty-seven out of 60 (78.3%; 65.8-87.9) children born alive were immunized for HBV within 24 hours of life. Retention in care was associated with the level of education of the infant's father, secondary school or higher was associated with a better retention in care of the women (OR: 6.6; P = .03). Our study shows large gaps in HBV PMTCT. Resources for hepatitis B screening, care and prevention including universal access to the vaccine birth dose should be allocated to reduce infection in HBV exposed infants born in Burkina Faso.
Sections du résumé
BACKGROUND
Prevention of mother-to-child transmission (PMTCT) is a challenge for controlling the hepatitis B epidemic. In Sub-Saharan countries, pilot interventions including the screening of pregnant women for HBsAg, implementation of anti-HBV therapy and infant immunization within 24 hours of life are initiated and need to be evaluated. This pilot study aimed to describe the cascade of care for hepatitis B PMTCT in a real life situation, and to identify sociodemographic factors associated with adequate management of pregnant women and infants.
METHOD
The study was conducted from October 1st, 2014 to February 28th, 2016 in the antenatal clinics (ANCV) of Baskuy district which comprises nine first-level public health centres. Univariate and multivariate logistic regression analysis were used to identify sociodemographic factors associated with the likelihood of retention in the cohort, HBV DNA testing, birth dose delivery and HBsAg testing of the children at 6 months of age; P ˂ .05 was selected as cut off for significance.
RESULTS
In this prospective cohort study, of 5200 pregnant women consulting for the antenatal visit, 2261 (43.5%) were proposed pre-test counselling and HBsAg screening and 2220 (98.2%) have agreed to screening. Among 1580 (71.2%) women that came back for the post-counselling interview, 75 were positive for HBsAg (4.8%), 73 (97.3% of the women provided HBsAg result) consented to medical consultation with hepatogastroenterologists and 53 (72.6%); performed the HBV DNA testing. Forty-seven out of 60 (78.3%; 65.8-87.9) children born alive were immunized for HBV within 24 hours of life. Retention in care was associated with the level of education of the infant's father, secondary school or higher was associated with a better retention in care of the women (OR: 6.6; P = .03).
CONCLUSION
Our study shows large gaps in HBV PMTCT. Resources for hepatitis B screening, care and prevention including universal access to the vaccine birth dose should be allocated to reduce infection in HBV exposed infants born in Burkina Faso.
Substances chimiques
Hepatitis B Surface Antigens
0
Hepatitis B Vaccines
0
Hepatitis B e Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2367-2376Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
World Health Organization. Guidelines on hepatitis B and C testing. 2016. https://apps.who.int/iris/bitstream/handle/10665/251330/WHO-HIV-2016.23-eng.pdf?sequence=1.
Howell J, Lemoine M, Thursz M. Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: The evidence, current practice and future challenges. J Viral Hepat. 2014;21:381-396.
Shimakawa Y, Toure-Kane C, Mendy M, Thursz M, Lemoine M. Mother-to-child transmission of hepatitis B in sub-Saharan Africa. Lancet Infect Dis. 2016;16:19-20.
Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. Global elimination of mother-to-child transmission of hepatitis B: Revisiting the current strategy. Lancet Infect Dis. 2015;15:981-985.
Progress report on HIV, viral hepatitis and sexually transmitted infections 2019;https://apps.who.int/iris/bitstream/handle/10665/324797/WHO-CDS-HIV-19.7-eng.pdf?ua=1.
World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
Song J, Yang F, Wang S, et al, Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat. 2019;26:397-406.
Lee C, Gong Y, Brok J, Boxall E, Gludd C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers (Review). Cochrane DatabaseSystRev. 2006;19:1-107.
Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment PharmacolTher. 2016;44:1005-1017.
Ekra D, Herbinger K-H, Konate S, et al, A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d’Ivoire. Vaccine. 2008;26:2753-2761.
Chen HL, Wen WH, Chang MH. Management of pregnant women and children: Focusing on preventing mother-to-infant transmission. J Infect Dis. 2017;216:785-791.
Nayagam S, Thursz M, Sicuri E, et al, Requirements for global elimination of hepatitis B: A modelling study. Lancet Infect Dis. 2016;16:1399-1408.
Meda N, Tuaillon E, Kania D, Tiendrebeogo A. Hepatitis B and C virus seroprevalence, Burkina Faso: A cross-sectional study. Bull World Health Organ. 2018;96:750-759.
ONUSIDA. Burkina Faso/ONUSIDA https://www.unaids.org/en/regionscountries/countries/burkinafaso.
CNLS-IST BURKINA FASO. Cadre stratégique de lutte contre le VIH/SIDA et les IST (CSLS) 2006-2010. http://www.ilo.org/wcmsp5/groups/public/--ed_protect/--protrav/--ilo_aids/documents/legaldocument/wcms_126291.pdf.
Giles-Vernick T, Hejoaka F, Sanou A, Shimakawa Y, Bamba I, Traore A. Barriers to linkage to care for hepatitis B virus infection: a qualitative analysis in Burkina Faso, west Africa. Am J Trop Med Hyg. 2016;95:1368-1375.
Dionne-Odom J, Tita AT, Silverman NS. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J ObstetGynecol. 2016;214:6-14.
Terrault NA, Bzowej NH, Chang K-M, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261-283.
National Institute of Statistics and Demography (INSD). Enquête démographique et de santé et à indicateurs multiples (edsbf-mics iv) 2010. https://dhsprogram.com/pubs/pdf/pr9/pr9.pdf.
Anaedobe CG, Fowotade A, Omoruyi CE, Bakare R Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in South western Nigeria. Pan Afr Med J. 2015;20:1-11.
Lohmann J, Souares A, Tiendrebéogo J, et al, Measuring health workers' motivation composition: Validation of a scale based on Self-Determination Theory in Burkina Faso. Hum Resour Health. 2017;15:1-12.
Guingané AN, Meda N, Sombié R, et al, Prevention of mother-to-child transmission of hepatitis B in the Urban District HealthBaskuy Burkina. Faso. Open Journal of Gastroenterology. 2016;6:175-187.
Ministère de la santé Burkina Faso. Tableau de bord 2015 des indicateurs de santé http://www.cns.bf/IMG/pdf/tableau_de_bord_2015_ms_vf.pdf.
Chotun N, Preiser W, van Rensburg CJ, et al, Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience. PLoS One. 2017;12:1-11.
Chevaliez S, Pawlotsky JM. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. JHepatol. 2018;69:916-926.
Bottero J, Boyd A, Gozlan J, et al, Simultaneous human immunodeficiency virus-hepatitis b-hepatitis C point-of-care tests improve outcomes in linkage-to-care: results of a randomized control trial in persons without healthcare coverage. Open Forum Infect Dis. 2015;2:1-8.
Daher J, Vijh R, Linthwaite B, et al, PaiNP. Do digital innovations for HIV and sexually transmitted infections work? Results from a systematic review (1996-2017). BMJ Open. 2017;7:1-11.
Hyun MH, Lee YS, Kim JH, et al, Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Aliment PharmacolTher. 2017;45:1493-1505.
World Health Organization library Cataloguing-in-Publication data. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. https://apps.who.int/iris/bitstream/handle/10665/154590/9789241549059_eng.pdf.
The world bank. GNI per capita, PPP (current international $). https://data.worldbank.org/indicator/NY.GNP.PCAP.PP.CD.
Ségéral O, N’Diaye DS, Prak S. 12328 12345 Study Group. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. J Clin Virol. 2018;109:29-34.
Sangaré L, Sombié R, Combasséré AW. Transmission anténatale du virus de l’hépatite B en zone de prévalence modérée du VIH, Ouagadougou. Burkina Faso. Bull SocPatholExot. 2009;102:226-229.
Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: Hepatitis B e antigen (HBeAg) prevalence estimation for all world regions. BMC Infect Dis. 2012;12:131-210.